Michael J. Donovan
Equibles does not estimate personal net worth.
Get an email with a short summary when Renalytix plc publishes a filing, an earnings call transcript or a press release.
Get RNLXY alertsAbout Michael J. Donovan
The proxy statement of Renalytix plc reports total compensation of $380,014 for Michael J. Donovan in fiscal 2024, including a base salary of $328,450. Renalytix plc is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Renalytix plc includes James McCullough (CEO and Board Member), Julian Baines MBE (Chairman and Board Member), Joel Jung (CFO) and 5 others.
Affiliation history
-
Renalytix plc (RNLXY)
Proxy statement
CurrentStart not stated–present
Last confirmed November 25, 2024
Company network
Leadership on record at Renalytix plc
- James McCullough CEO, Board Member
- Julian Baines MBE Chairman, Board Member
- Joel Jung CFO
- Joel R. Jung CFO
- Catherine Coste Board Member
- Christopher Mills Board Member
- Erik Lium Board Member
- Fergus Fleming Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Renalytix plc (RNLXY) | Chief Medical Officer | $328,450 | $380,014 |
Recent activity
No call appearances or filed executive changes recorded yet.